butyric acid and gefitinib

butyric acid has been researched along with gefitinib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujita, M; Hara, M; Ito, Y; Kanemitsu, Y; Kondo, E; Nakanishi, H; Nakata, S; Tanaka, H; Yatabe, Y	1

Other Studies

1 other study(ies) available for butyric acid and gefitinib

Article	Year
Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity. International journal of oncology, 2014, Volume: 45, Issue:4 Topics: Animals; Antineoplastic Agents; Butyric Acid; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Colorectal Neoplasms; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Xenograft Model Antitumor Assays	2014

Article

Year

Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity.

International journal of oncology, 2014, Volume: 45, Issue:4

Topics: Animals; Antineoplastic Agents; Butyric Acid; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Colorectal Neoplasms; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Xenograft Model Antitumor Assays

2014